RxNorm Semantic Concepts Index - 486
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "486".
Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
---|---|---|---|---|
Concept ID (RxCUI): 486015 | chlorothen 0.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486016 | chlorothen / methapyrilene / pyrilamine Topical Lotion | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
Concept ID (RxCUI): 486017 | chlorothen 0.06 % / methapyrilene HCl 0.22 % / pyrilamine 0.22 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 486017 | chlorothen 0.06 % / methapyrilene HCl 0.22 % / pyrilamine 0.22 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
Concept ID (RxCUI): 486017 | chlorothen 0.06 % / methapyrilene HCl 0.22 % / pyrilamine 0.22 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486018 | chymotrypsin 0.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486019 | chymotrypsin 0.2 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486040 | citric acid 60 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486041 | citric acid / sodium citrate Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
Concept ID (RxCUI): 486042 | citric acid 300 MG / sodium citrate 500 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
Concept ID (RxCUI): 486042 | citric acid 300 MG / sodium citrate 500 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 486042 | citric acid 300 MG / sodium citrate 500 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486061 | cefonicid 325 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486063 | cephapirin 417 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486067 | papain 830000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486068 | papain / urea Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
Concept ID (RxCUI): 486076 | urea 0.01 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486077 | papain 830000 UNT / urea 0.01 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486079 | cephalothin 4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486080 | cephalothin 4 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486081 | urea 0.1 UNT/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486082 | papain 830000 UNT / urea 0.1 UNT/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486083 | papain 830000 UNT / urea 0.1 UNT/MG [Gladase] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
Concept ID (RxCUI): 486084 | papain 830000 UNT / urea 0.1 UNT/MG Topical Ointment [Gladase] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
Concept ID (RxCUI): 486085 | cephalothin 2.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486086 | cephalothin 2.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486087 | cephalothin 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486088 | cephalothin 5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486089 | cephalothin 0.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486090 | cephalothin 0.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486091 | cephalothin 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486095 | papain 830 UNT/MG / urea 0.1 MG/MG [Kovia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
Concept ID (RxCUI): 486096 | Kovia 830,000 UNT/GM / 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 486096 | Kovia 830,000 UNT/GM / 10 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
Concept ID (RxCUI): 486096 | Kovia 830,000 UNT/GM / 10 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
Concept ID (RxCUI): 486098 | papain 830 UNT/MG / urea 0.1 MG/MG [Gladase] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
Concept ID (RxCUI): 486099 | Gladase 830,000 UNT/GM / 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 486099 | Gladase 830,000 UNT/GM / 10 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
Concept ID (RxCUI): 486099 | Gladase 830,000 UNT/GM / 10 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
Concept ID (RxCUI): 486103 | Lumicain | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
Concept ID (RxCUI): 486104 | aluminum chloride 250 MG/ML [Lumicain] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
Concept ID (RxCUI): 486107 | aluminum chloride Topical Solution [Lumicain] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
Concept ID (RxCUI): 486109 | lumicain 25 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
Concept ID (RxCUI): 486109 | lumicain 25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
Concept ID (RxCUI): 486109 | lumicain 25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486109 | lumicain 25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486113 | neomycin 0.005 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486114 | polymyxin B 0.4 UNT/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486115 | bacitracin 0.5 UNT/MG / neomycin 0.005 MG / polymyxin B 0.4 UNT/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486118 | bacitracin 500 UNT / neomycin 5 MG / polymyxin B 400 UNT per GM Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486118 | bacitracin 500 UNT / neomycin 5 MG / polymyxin B 400 UNT per GM Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
Concept ID (RxCUI): 486118 | bacitracin 500 UNT / neomycin 5 MG / polymyxin B 400 UNT per GM Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 486120 | iron fumarate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
Concept ID (RxCUI): 486126 | ziconotide acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
Concept ID (RxCUI): 486126 | ziconotide acetate | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 486126 | ziconotide acetate | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 486131 | benzoyl peroxide 10 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
Concept ID (RxCUI): 486131 | benzoyl peroxide 10 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
Concept ID (RxCUI): 486131 | benzoyl peroxide 10 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486131 | benzoyl peroxide 10 % Topical Gel | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 486131 | benzoyl peroxide 10 % Topical Gel | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 486133 | ziconotide acetate 500 MCG in 20 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
Concept ID (RxCUI): 486133 | ziconotide acetate 500 MCG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
Concept ID (RxCUI): 486133 | ziconotide acetate 500 MCG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486137 | papain 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486138 | chlorophyll / papain / urea Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
Concept ID (RxCUI): 486139 | chlorophyll 5 MG/ML / papain 100 MG/ML / urea 100 MG/ML Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486140 | estradiol 0.00156 MG/HR [Climara] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
Concept ID (RxCUI): 486145 | nitroglycerin 0.6 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
Concept ID (RxCUI): 486146 | nitroglycerin 0.6 MG/HR 24HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
Concept ID (RxCUI): 486146 | nitroglycerin 0.6 MG/HR 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486146 | nitroglycerin 0.6 MG/HR 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486146 | nitroglycerin 0.6 MG/HR 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486146 | nitroglycerin 0.6 MG/HR 24HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
Concept ID (RxCUI): 486146 | nitroglycerin 0.6 MG/HR 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486146 | nitroglycerin 0.6 MG/HR 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486146 | nitroglycerin 0.6 MG/HR 24HR Transdermal System | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 486146 | nitroglycerin 0.6 MG/HR 24HR Transdermal System | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 486147 | nitroglycerin 0.2 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
Concept ID (RxCUI): 486148 | nitroglycerin 0.2 MG/HR 24HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
Concept ID (RxCUI): 486148 | nitroglycerin 0.2 MG/HR 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486148 | nitroglycerin 0.2 MG/HR 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486148 | nitroglycerin 0.2 MG/HR 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486148 | nitroglycerin 0.2 MG/HR 24HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
Concept ID (RxCUI): 486148 | nitroglycerin 0.2 MG/HR 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486148 | nitroglycerin 0.2 MG/HR 24HR Transdermal System | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 486148 | nitroglycerin 0.2 MG/HR 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486148 | nitroglycerin 0.2 MG/HR 24HR Transdermal System | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 486151 | nitroglycerin 0.4 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
Concept ID (RxCUI): 486152 | nitroglycerin 0.4 MG/HR 24HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
Concept ID (RxCUI): 486152 | nitroglycerin 0.4 MG/HR 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486152 | nitroglycerin 0.4 MG/HR 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486152 | nitroglycerin 0.4 MG/HR 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486152 | nitroglycerin 0.4 MG/HR 24HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
Concept ID (RxCUI): 486152 | nitroglycerin 0.4 MG/HR 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486152 | nitroglycerin 0.4 MG/HR 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486152 | nitroglycerin 0.4 MG/HR 24HR Transdermal System | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 486152 | nitroglycerin 0.4 MG/HR 24HR Transdermal System | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 486154 | estradiol 0.00104 MG/HR [Alora] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
Concept ID (RxCUI): 486155 | Alora 0.025 MG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486155 | Alora 0.025 MG/Day Twice Weekly Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
Concept ID (RxCUI): 486155 | Alora 0.025 MG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486155 | Alora 0.025 MG/Day Twice Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
Concept ID (RxCUI): 486155 | Alora 0.025 MG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486156 | estradiol 0.00188 MG/HR / levonorgestrel 0.000625 MG/HR [Climara Pro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
Concept ID (RxCUI): 486157 | testosterone 0.208 MG/HR [Testoderm] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
Concept ID (RxCUI): 486162 | nicotine 0.313 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486164 | Ovine hyaluronidase | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
Concept ID (RxCUI): 486164 | Ovine hyaluronidase | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 486164 | Ovine hyaluronidase | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 486164 | Ovine hyaluronidase | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 486164 | Ovine hyaluronidase | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 486166 | hyaluronidase, ovine 200 UNT/ML in 1.2 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
Concept ID (RxCUI): 486166 | hyaluronidase, ovine 200 UNT/ML in 1.2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
Concept ID (RxCUI): 486166 | hyaluronidase, ovine 200 UNT/ML in 1.2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486179 | lanolin 0.02 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486180 | petrolatum 0.83 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
Concept ID (RxCUI): 486181 | lanolin / mineral oil / petrolatum Ophthalmic Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
Concept ID (RxCUI): 486182 | lanolin 2 % / mineral oil 15 % / petrolatum 83 % Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486182 | lanolin 2 % / mineral oil 15 % / petrolatum 83 % Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
Concept ID (RxCUI): 486182 | lanolin 2 % / mineral oil 15 % / petrolatum 83 % Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 486184 | mineral oil 0.415 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
Concept ID (RxCUI): 486185 | mineral oil 41.5 % / petrolatum 55 % Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486185 | mineral oil 41.5 % / petrolatum 55 % Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
Concept ID (RxCUI): 486185 | mineral oil 41.5 % / petrolatum 55 % Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 486186 | mineral oil 0.425 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
Concept ID (RxCUI): 486187 | petrolatum 0.555 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486188 | mineral oil 42.5 % / petrolatum 55.5 % Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486188 | mineral oil 42.5 % / petrolatum 55.5 % Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
Concept ID (RxCUI): 486188 | mineral oil 42.5 % / petrolatum 55.5 % Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 486246 | stannous fluoride 16.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
Concept ID (RxCUI): 486247 | stannous fluoride 1.64 % (fluoride ion 1.6 % ) Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
Concept ID (RxCUI): 486247 | stannous fluoride 1.64 % (fluoride ion 1.6 % ) Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486247 | stannous fluoride 1.64 % (fluoride ion 1.6 % ) Mouthwash | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
Concept ID (RxCUI): 486248 | stannous fluoride 40 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486249 | stannous fluoride 4 % Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
Concept ID (RxCUI): 486249 | stannous fluoride 4 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 486249 | stannous fluoride 4 % Mouthwash | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486329 | didanosine 16.7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486330 | ddI 16.7 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 486330 | ddI 16.7 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486330 | ddI 16.7 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 486331 | cycloSPORINE 100 MG/ML [SandIMMUNE] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
Concept ID (RxCUI): 486331 | cycloSPORINE 100 MG/ML [SandIMMUNE] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
Concept ID (RxCUI): 486375 | o-phthalaldehyde 5.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486376 | o-phthalaldehyde Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
Concept ID (RxCUI): 486377 | o-phthalaldehyde 5.5 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486394 | activated charcoal 250 MG / simethicone 125 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 4864 | Glucose-6-phosphatase | Designated preferred name (PT) | NO | |
Concept ID (RxCUI): 4864 | Glucose-6-phosphatase | Full form of descriptor (FN) | NO | |
Concept ID (RxCUI): 486417 | clofarabine 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
Concept ID (RxCUI): 486419 | clofarabine 20 MG in 20 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
Concept ID (RxCUI): 486419 | clofarabine 20 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
Concept ID (RxCUI): 486419 | clofarabine 20 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486438 | ubidecarenone 600 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
Concept ID (RxCUI): 486439 | ubidecarenone 600 MG Oral Wafer | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
Concept ID (RxCUI): 486439 | ubidecarenone 600 MG Oral Wafer | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
Concept ID (RxCUI): 486439 | ubidecarenone 600 MG Oral Wafer | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486454 | mecobalamin 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486456 | methylfolic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
Concept ID (RxCUI): 486487 | brompheniramine / pseudoephedrine Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
Concept ID (RxCUI): 486499 | esomeprazole 20 MG Injection | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 486499 | esomeprazole 20 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486499 | esomeprazole 20 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
Concept ID (RxCUI): 486499 | esomeprazole 20 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
Concept ID (RxCUI): 486499 | esomeprazole 20 MG Injection | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 4865 | G-6PD | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 4865 | G-6PD | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 4865 | G-6PD | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 4865 | G-6PD | Designated preferred name (PT) | NO | |
Concept ID (RxCUI): 4865 | G-6PD | Full form of descriptor (FN) | NO | |
Concept ID (RxCUI): 486501 | esomeprazole 40 MG Injection | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 486501 | esomeprazole 40 MG Injection | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 486501 | esomeprazole 40 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486501 | esomeprazole 40 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
Concept ID (RxCUI): 486501 | esomeprazole 40 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
Concept ID (RxCUI): 486501 | esomeprazole 40 MG Injection | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 486501 | esomeprazole 40 MG Injection | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 486501 | esomeprazole 40 MG Injection | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 486501 | esomeprazole 40 MG Injection | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 486505 | pramlintide Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
Concept ID (RxCUI): 486510 | palifermin 6.25 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
Concept ID (RxCUI): 486510 | palifermin 6.25 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
Concept ID (RxCUI): 486510 | palifermin 6.25 MG Injection | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 486510 | palifermin 6.25 MG Injection | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 486515 | sodium chloride 0.9 % Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486515 | sodium chloride 0.9 % Irrigation Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
Concept ID (RxCUI): 486515 | sodium chloride 0.9 % Irrigation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
Concept ID (RxCUI): 486515 | sodium chloride 0.9 % Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 486527 | guaifenesin / hydrocodone / phenylpropanolamine / salicylamide Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
Concept ID (RxCUI): 486527 | guaifenesin / hydrocodone / phenylpropanolamine / salicylamide Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
Concept ID (RxCUI): 486533 | guaifenesin / phenylpropanolamine Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
Concept ID (RxCUI): 486533 | guaifenesin / phenylpropanolamine Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
Concept ID (RxCUI): 486538 | sodium phosphate 4.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486539 | sodium phosphate, monobasic 4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486540 | sodium phosphate / sodium phosphate, monobasic Ophthalmic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
Concept ID (RxCUI): 486541 | sodium phosphate 4.5 MG/ML / sodium phosphate, monobasic 4 MG/ML Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
Concept ID (RxCUI): 486541 | sodium phosphate 4.5 MG/ML / sodium phosphate, monobasic 4 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486562 | chlorpheniramine / pyrilamine Topical Lotion | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
Concept ID (RxCUI): 486565 | chlorpheniramine / hydrocortisone / pheniramine / pyrilamine Topical Lotion | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
Concept ID (RxCUI): 486574 | chlorpheniramine 0.5 MG/ML / phenylephrine 1.2 MG/ML / phenylpropanolamine 5 MG/ML / phenyltoloxamine 2 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486610 | paclitaxel protein-bound | Designated preferred name (PT) | NO | |
Concept ID (RxCUI): 486610 | paclitaxel protein-bound | Full form of descriptor (FN) | NO | |
Concept ID (RxCUI): 486610 | paclitaxel protein-bound | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
Concept ID (RxCUI): 486610 | paclitaxel protein-bound | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
Concept ID (RxCUI): 486672 | fentaNYL 0.003 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486672 | fentaNYL 0.003 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
Concept ID (RxCUI): 4867 | Phosphohexose isomerase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 4867 | Phosphohexose isomerase | Designated preferred name (PT) | NO | |
Concept ID (RxCUI): 4867 | Phosphohexose isomerase | Full form of descriptor (FN) | NO | |
Concept ID (RxCUI): 4867 | Phosphohexose isomerase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 4867 | Phosphohexose isomerase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 4867 | Phosphohexose isomerase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 4867 | Phosphohexose isomerase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 4867 | Phosphohexose isomerase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 486747 | lutropin alfa 75 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486762 | guaiFENesin 1.67 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486762 | guaiFENesin 1.67 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
Concept ID (RxCUI): 4868 | Glucose-1-phosphate uridylyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 4868 | Glucose-1-phosphate uridylyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 4868 | Glucose-1-phosphate uridylyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 4868 | Glucose-1-phosphate uridylyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 4868 | Glucose-1-phosphate uridylyltransferase | Full form of descriptor (FN) | NO | |
Concept ID (RxCUI): 4868 | Glucose-1-phosphate uridylyltransferase | Designated preferred name (PT) | NO | |
Concept ID (RxCUI): 486895 | magnesium amino acid chelate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
Concept ID (RxCUI): 486895 | magnesium amino acid chelate | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 486895 | magnesium amino acid chelate | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 486896 | magnesium amino acid chelate 27 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486897 | magnesium amino acid chelate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
Concept ID (RxCUI): 486898 | magnesium amino acid chelate 27 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
Concept ID (RxCUI): 486898 | magnesium amino acid chelate 27 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486911 | erythromycin estolate 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486912 | erythromycin estolate 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
Concept ID (RxCUI): 486912 | erythromycin estolate 500 MG Oral Tablet | Designated preferred name (PT) | NO | |
Concept ID (RxCUI): 486912 | erythromycin estolate 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486912 | erythromycin estolate 500 MG Oral Tablet | Full form of descriptor (FN) | NO | |
Concept ID (RxCUI): 48695 | D-lactic acid dehydrogenase | Designated preferred name (PT) | NO | |
Concept ID (RxCUI): 48695 | D-lactic acid dehydrogenase | Full form of descriptor (FN) | NO | |
Concept ID (RxCUI): 48695 | D-lactic acid dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 486953 | erythromycin estolate 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486955 | erythromycin estolate 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
Concept ID (RxCUI): 486955 | erythromycin estolate 250 MG Oral Capsule | Designated preferred name (PT) | NO | |
Concept ID (RxCUI): 486955 | erythromycin estolate 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486955 | erythromycin estolate 250 MG Oral Capsule | Full form of descriptor (FN) | NO | |
Concept ID (RxCUI): 486956 | erythromycin estolate 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486959 | erythromycin estolate 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486960 | Erythromycin estolate 25 mg/mL oral suspension | Designated preferred name (PT) | NO | |
Concept ID (RxCUI): 486960 | Erythromycin estolate 25 mg/mL oral suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 486960 | Erythromycin estolate 25 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
Concept ID (RxCUI): 486961 | phosphate ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
Concept ID (RxCUI): 486965 | erythromycin estolate 125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 486990 | erythromycin estolate 25 MG/ML [Ilosone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |